Relapse Myeloma; Cyclofosfamide; Bortezomib; Maintenance

NCT02467010 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bortezomib
DRUG: Cyclophosphamide
DRUG: Dexamethasone

Sponsor

University Medical Center Groningen